GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext?dgcid=hubspot_update_feature_updatealerts_eclinm&utm_campaign=update-eclinm&utm_medium=email&_hsenc=p2ANqtz-_ni0GNbeCaGaEOwepay32UzHbVWg_nMbfZPXzuPPSjN9cS35IMuFHhWevn5n6shuR-1OaSPGs1wj3xWKEHMO2FC5CWYA&_hsmi=318647597&utm_content=318128062&utm_source=hs_email